DR Profile
Alchemia
Business Summary
Alchemia is a biotechnology company. The Company is engaged in the research and development of human therapeutics based on its proprietary drug discovery, dry targeting and synthesis technologies. The Company has two promising late stage assets in generic foundaparinux and HA-Irinotecan. The Company carried out its operations primarily in Australia and the United States.
Data provided by Mergent, Inc.Recent Company News
Powered by Interactive Data Managed Solutions
Recent / Upcoming DR Events
Data provided by Thomson Reuters, Inc.
| DR Symbol | AEMAY |
| CUSIP | 01374K101 |
| DR Exchange | OTC |
| DR ISIN | US01374K1016 |
| Ratio | 1:10 |
| Depositary | BK (Sponsored) |
| Effective Date | Nov 03, 2004 |
| Underlying ISIN | AU000000ACL6 |
| Underlying SEDOL | 6716408 |
| Country | Australia |
| Industry | Pharma. & Biotech. |
Monthly DR Trading Summary
| Month |
Month End DR Close Price |
DR Trading Volume |
Avg Day DR Trading Volume |
|---|---|---|---|
 Apr. 13 |
4.00 | n/a | n/a |
| Mar. 13 |
3.44 | n/a | n/a |
| Feb. 13 |
3.33 | n/a | n/a |
This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE
